The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
5040499 6066683 F 5040499-3 20060425 20060508 20060630 EXP US-ROCHE-447409 ROCHE 45 YR M Y 67.1 KG 20060630 MD UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
5040499 1007431424 PS PEGASYS 1 SUBCUTANEOUS
5040499 1007431425 SS RIBAVIRIN 1 ORAL 021511

Indications of drugs used

Event ID DRUG SEQ INDI PT
5040499 1007431424 HEPATITIS C
5040499 1007431425 HEPATITIS C

Outcome of event

Event ID OUTC COD
5040499 HO

Reactions reported

Event ID PT
5040499 ANXIETY
5040499 BRONCHITIS
5040499 DEPRESSION
5040499 HYPERVENTILATION

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
5040499 1007431424 20060127
5040499 1007431425 20060127